P-558 Phase-II trial of topotecan and etoposide in extensive disease small cell lung cancer (ED-SCLC)

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S232
Author(s):  
Martin Reck ◽  
Erika Buchholz ◽  
Gesine Groth ◽  
Sabine Kaubitzsch ◽  
Ulrich Gatzemeier ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Disease

scholarly journals P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial

2007 ◽  
Vol 2 (8) ◽  
pp. S824
Author(s):  
Andriani G. Charpidou ◽  
Nikolaos Katirtzoglou ◽  
Ioannis Gkiozos ◽  
Eleni Karapanagiotou ◽  
Anna Rigopoulou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Front Line ◽  
Small Cell Lung ◽  
Extensive Disease

A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer

Lung Cancer ◽  
2006 ◽  
Vol 54 (3) ◽  
pp. 365-370 ◽  
Author(s):  
Joo Hyuk Sohn ◽  
Hye Jin Choi ◽  
Joon Chang ◽  
Se Kyu Kim ◽  
Chang Geal Lee ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Disease

Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: A randomized phase II trial

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7046-7046 ◽  
Author(s):  
A. Schmittel ◽  
L. Fischer von Weikersthal ◽  
M. Sebastian ◽  
H. Link ◽  
K. Schulze ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Disease ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document